Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III

Journal of Child Neurology

Volumn 26, Issue 12, 2011, Pages 1499-1507

  Glanzman, Allan M ^a   O'Hagen, Jessica M ^b   McDermott, Michael P ^c   Martens, William B ^c   Flickinger, Jean ^a   Riley, Susan ^a   Quigley, Janet ^a   Montes, Jacqueline ^b   Dunaway, Sally ^b   Deng, Liyong ^b,d   Chung, Wendy K ^b   Tawil, Rabi ^c   Darras, Basil T ^d,e   De Vivo, Darryl C ^b   Kaufmann, Petra ^b   Finkel, Richard S ^a,f  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Gross Motor Function Measure; Hammersmith Functional Motor Scale; spinal muscular atrophy

Indexed keywords

ADULT; AGED; AIRWAY PRESSURE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; COPY NUMBER VARIATION; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; ELBOW FLEXION; EXPANDED HAMMERSMITH FUNCTIONAL MOTOR SCALE; FEMALE; FORCED VITAL CAPACITY; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; GENE DELETION; GENOTYPE; GROSS MOTOR FUNCTION CLASSIFICATION SYSTEM; HUMAN; INTERMETHOD COMPARISON; KNEE FUNCTION; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; MUSCLE STRENGTH; PRIORITY JOURNAL; RATING SCALE; RESPIRATORY FUNCTION; SPINAL MUSCULAR ATROPHY; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; DISABILITY EVALUATION; FEMALE; HUMANS; KNEE; MALE; MIDDLE AGED; MOTOR ACTIVITY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SPINAL MUSCULAR ATROPHIES OF CHILDHOOD; STATISTICS, NONPARAMETRIC; VITAL CAPACITY;

EID: 82455168056     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073811420294     Document Type: Conference Paper

References (28)

1. Ludvigsson P, Olafsson E, Hauser WA. Spinal muscular atrophy. Incidence in Iceland. Neuroepidemiology. 1999 ; 18 (5). 265-269 (Pubitemid 29399849)
2. Lefebvre S, Burglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995 ; 80 (1). 155-165
3. Sumner CJ. Molecular mechanisms of spinal muscular atrophy. J Child Neurol. 2007 ; 22 (8). 979-989 (Pubitemid 47308312)
4. Zhang Z, Lotti F, Dittmar K, et al. SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell. 2008 ; 133 (4). 585-600 (Pubitemid 351636302)
5. Beattie CE, Carrel TL, McWhorter ML. Fishing for a mechanism: using zebrafish to understand spinal muscular atrophy. J Child Neurol. 2007 ; 22 (8). 995-1003 (Pubitemid 47308314)
6. Zerres K, Rudnik-Schoneborn S. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol. 1995 ; 52 (5). 518-523
7. Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002 ; 70 (2). 358-368 (Pubitemid 34112291)
8. Sumner CJ. Therapeutics development for spinal muscular atrophy. NeuroRx. 2006 ; 3 (2). 235-245 (Pubitemid 44061706)
9. Krosschell KJ, Maczulski JA, Crawford TO, Scott C, Swoboda KJ. A modified Hammersmith Functional Motor Scale for use in multi-center research on spinal muscular atrophy. Neuromuscul Disord. 2006 ; 16 (7). 417-426 (Pubitemid 44109971)
10. Kaufmann P, Muntoni F. Issues in SMA clinical trial design. The International Coordinating Committee (ICC) for SMA Subcommittee on SMA Clinical Trial Design. Neuromuscul Disord. 2007 ; 17 (6). 499-505 (Pubitemid 46783444)
11. Mendell JR, Csimma C, McDonald CM, et al. Challenges in drug development for muscle disease: a stakeholders' meeting. Muscle & Nerve. 2007 ; 35 (1). 8-16 (Pubitemid 46061362)
12. Main M, Kairon H, Mercuri E, Muntoni F. The Hammersmith Functional Motor Scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol. 2003 ; 7 (4). 155-159 (Pubitemid 36939996)
13. Boyce WF, Gowland C, Hardy S, et al. Development of a quality-of-movement measure for children with cerebral palsy. Phys Ther. 1991 ; 71 (11). 820 828-828 832
14. Nelson L, Owens H, Hynan LS, Iannaccone ST. The Gross Motor Function Measure is a valid and sensitive outcome measure for spinal muscular atrophy. Neuromuscul Disord. 2006 ; 16 (6). 374-380 (Pubitemid 43870324)
15. Tiziano FD, Bertini E, Messina S, et al. The Hammersmith functional score correlates with the SMN2 copy number: a multicentric study. Neuromuscul Disord. 2007 ; 17 (5). 400-403 (Pubitemid 46679240)
16. Mercuri E, Bertini E, Messina S, et al. Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. Neurology. 2007 ; 68 (1). 51-55 (Pubitemid 46058552)
17. KrosschellKMaczulskiJA.Modified Hammersmith Functional Motor Scale for children with spinal muscular atrophy: research trial protocol administration and scoring manual. http://smaoutcomes.org/hammersmith-manual/manual-1.html.
18. Mazzone E, Bianco F, Martinelli D, et al. Assessing upper limb function in nonambulant SMA patients: development of a new module. Neuromuscul Disord. 2011 ; 21 (6). 406-12
19. O'Hagen JM, Glanzman AM, McDermott MP, et al. An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. Neuromuscul Disord. 2007 ; 17 (9-10). 693-697 (Pubitemid 47362680)
20. Russell DJ, Rosenbaum P, Avery LM, Lane M. The Gross Motor Function Measure user's manual. Clin Dev Med. 2002 ;: 159
21. Iannaccone ST, Hynan LS. Reliability of 4 outcome measures in pediatric spinal muscular atrophy. Arch Neurol. 2003 ; 60 (8). 1130-1136 (Pubitemid 36975803)
22. Merlini L, Mazzone ES, Solari A, Morandi L. Reliability of hand-held dynamometry in spinal muscular atrophy. Muscle Nerve. 2002 ; 26 (1). 64-70 (Pubitemid 34734397)
23. Wang CH, Finkel RS, Bertini ES, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007 ; 22 (8). 1027-1049 (Pubitemid 47308318)
24. Bertini E, Burghes A, Bushby K, et al. 134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy; Feb 11-13, 2005; Naarden, the Netherlands. Neuromuscul Disord. 2005 ; 15 (11). 802-816 (Pubitemid 41476298)
25. Hirtz D, Iannaccone S, Heemskerk J, Gwinn-Hardy K, Moxley R 3rd, Rowland LP. Challenges and opportunities in clinical trials for spinal muscular atrophy. Neurology. 2005 ; 65 (9). 1352-1357 (Pubitemid 41552760)
26. Iannaccone ST. Outcome measures for pediatric spinal muscular atrophy. Arch Neurol. 2002 ; 59 (9). 1445-1450 (Pubitemid 35014809)
27. Stratigopoulos GL, Lanzano P, Deng L, et al. Association of plastin 3 expression is associated with disease severity in spinal muscular atrophy only in postpubertal females. Arch Neurol. 2010 ; 67 (10). 1252-1256
28. Swoboda KJ, Kissel JT, Crawford TO, et al. Perspectives on clinical trials in spinal muscular atrophy. J Child Neurol. 2007 ; 22 (8). 957-966 (Pubitemid 47308309)